PharmaVOICE - 
December 2005
Purchase Issue

In Every Issue
Year in Preview — Featured Experts
Featured Experts Indexed by Section Introduction Introduction Murray Aitken. IMS [...]
By
Year in Preview — Thought Leaders
Thought Leaders Listed in Alphabetical Order December 2005 Year in [...]
By
Letter from the Editor
PharmaVOICE is pleased to present our annual Year in Preview [...]
By

Taren Grom, Editor

On The Cover

Tracking the Trends: The Industry Across Sectors
From the clinic to the market to the boardroom, a plethora of factors are expected to change the healthcare landscape in the coming year and beyond. More than 135 distinguished industry executives, representing all of the major sectors of the life-sciences industry, provide their insights on the hot topics and discuss how these market shapers [...]
By

Taren Grom and Denise Myshko

Features

The Medicine Cabinet
Compounds have a one in nine chance of making it through development, according to statistics, but even after reaching the market, each compound faces a whole new set of hurdles: physician adoption, reimbursement, and exposure to supply chain vulnerabilities. December 2005 On the Market Advertising/ Consumer Promotion The pros and cons of direct-to-consumer (DTC) advertising [...]
By
In the Boardroom
From defining and redefining organizational business models for big pharma, biotech, and emerging pharma to tactical decisions related to developing generic defense strategies to improving communications and corporate reputation plans to grappling with technology issues, today’s pharmaceutical leaders are relying on business-savvy solutions. Business and Organizational Models According to some industry analysts, the new pharma [...]
By
In the Clinic: Trials & Tribulations
Stakeholders involved with drug development and the clinical-trial process are rising to the challenges to improve efficiencies, reduce costs, and accelerate time lines. Systematic elegant approaches borrowing from areas such as intelligence analysis are at hand. Enhanced product characterization will be achieved with reduced investments. The solution is less about technology and more about a [...]
By
FEEDBACK